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Abstract The rat liver carnitine palmitoyltransferase 1 (L-CPT
1) expressed in Saccharomyces cerevisiae was correctly inserted
into the outer mitochondrial membrane and shared the same
folded conformation as the native enzyme found in rat liver
mitochondria. Comparison of the biochemical properties of the
yeast-expressed L-CPT 1 with those of the native protein
revealed the same detergent lability and similar sensitivity to
malonyl-CoA inhibition and affinity for carnitine. Normal
Michaelis-Menten kinetics towards palmitoyl-CoA were ob-
served when careful experimental conditions were used for the
CPT assay. Thus, the expression in S. cerevisiae is a valid model
to study the structure-function relationships of L-CPT 1.
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1. Introduction
The carnitine palmitoyltransferase (CPT; EC 2.3.1.21) en-
zyme system, in conjunction with carnitine/acylcarnitine trans-
locase, provides the mechanism whereby long-chain fatty
acids are transferred from the cytosol to the mitochondrial
matrix to undergo L-oxidation (reviewed in [1]). The CPT
system consists of two mitochondrial membrane-bound en-
zymes, CPT 1 and CPT 2. CPT 1 is an integral protein of
the outer mitochondrial membrane (OMM), it is speci¢cally
inhibited by malonyl-CoA, the ¢rst committed intermediate of
fatty acid biosynthesis, and it loses activity upon solubiliza-
tion of mitochondria by strong detergents. By contrast, CPT 2
is located on the inner face of the inner mitochondrial mem-
brane (IMM), is insensitive to malonyl-CoA inhibition and is
released in active soluble form by detergents (reviewed in [2]).
Inhibition of CPT 1 by malonyl-CoA plays a major role in the
physiological regulation of fatty acid oxidation [1]. Only one
CPT 2 isoform has been found, whereas two isoforms of CPT
1, encoded by distinct genes, have been described: the liver
form (L-CPT 1) and the muscle form (M-CPT 1) (reviewed in
[2]). Unlike M-CPT 1, L-CPT 1 displays altered sensitivity to
malonyl-CoA under di¡erent physiopathological conditions
(reviewed in [1]).
Elucidation of the molecular mechanisms involved in CPT 1
regulation by malonyl-CoA would be greatly facilitated by the
development of an appropriate expression system that permits
structure-function analysis of this key regulatory enzyme. De-
spite its usefulness for certain purposes [3,4], overexpression
of L-CPT 1 in COS-1 cells is not suitable for functional stud-
ies, as these cells have endogenous CPT 1 and 2 activities.
Although transfection in COS-1 cells has been used to analyze
the biochemical properties of human CPT 2 mutants [5,6],
these kinetic studies must be interpreted with caution due to
the presence of endogenous CPTs. The yeast system is a more
suitable model because of the complete absence of endoge-
nous CPT [7]. Rat liver CPT 1 has been previously expressed
in di¡erent strains of yeast [7,8]. However, in the ¢rst study
the level of expression in Saccharomyces cerevisiae was very
low [7] and in the second study the functional analysis (Km for
the substrates, IC50 for malonyl-CoA) of the enzyme ex-
pressed in Pichia pastoris was crude and never compared
with the one of the native L-CPT 1 present in rat liver mito-
chondria [8]. For example, it was not known whether the rat
L-CPT 1 expressed in yeast was correctly targeted to the
OMM and adopted a conformation similar to the native en-
zyme. In addition, non-Michaelis-Menten kinetics towards
palmitoyl-CoA of the rat L-CPT 1 expressed in yeast were
reported [8]. The inability to measure the apparent Km for
palmitoyl-CoA of the yeast-expressed L-CPT 1 prevents fur-
ther structure-function analysis such as determination of the
amino acid residues involved in binding the palmitoyl-CoA
substrate. The aim of the present study was to determine
whether rat L-CPT 1 expression in S. cerevisiae could be
improved and, secondly, to perform a more precise validation
of this yeast expression model by determining if the yeast-ex-
pressed enzyme does indeed have the same topological and
biochemical properties as the native protein.
2. Materials and methods
2.1. Plasmid construction for yeast expression of the rat L-CPT 1
and transformation of yeast cells
The cDNA for rat L-CPT 1 was excised from the pYes2.0-CPT1
vector [7] using restriction enzyme EcoRI and inserted into the
pGEM4 plasmid (pGEM4-CPT1). This L-CPT 1 cDNA contains a
3P non-coding region that was further deleted for yeast expression.
pGEM4-CPT1v3P was formed by deletion of the small SalI fragment
(encoding amino acids 669^773 and containing the stop codon and the
3P non-coding region). The polymerase chain reaction (PCR) was then
performed to copy a 338-nucleotide stretch of the 3P coding sequence
by using the 5P primer (5P-TATGTGGTGTCCAAGTAT-3P) located
upstream the unique SalI restriction site of L-CPT 1 cDNA and the 3P
primer (5P-CCCGCTCGAGTTACTTTTTAGAATTGAT-3P) con-
taining the stop codon and a XhoI restriction site. Replacement of
the original SalI fragment of the pGEM4-CPT1 with this PCR frag-
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ment cut by SalI and XhoI resulted in the generation of the pGEM4-
CPT1v3P plasmid.
For expression in S. cerevisiae, L-CPT 1 cDNA was excised from
pGEM4-CPT1v3P using the EcoRI and HindIII restriction enzymes.
The EcoRI-blunted HindIII fragment was inserted into the yeast ex-
pression pYeDP1/8-10 vector [9] cut by EcoRI and SmaI. The L-CPT
1 cDNA was placed immediately downstream of the inducible GAL10
promoter. The resulting plasmid was used to transform S. cerevisiae
(haploid strain W303: MATa, his3, leu2, trp1, ura3, ade2-1, can1-100)
according to [10]. The multicopy pYeDP1/8-10 plasmid contains the
URA3 gene, allowing selection of transformants by plating on a min-
imal medium lacking uracil. The transformed colonies were then
grown on liquid selecting medium in the presence of 2% galactose
and harvested during the exponential growth phase. Crude cell ex-
tracts were prepared [11] and used for Western blotting experiments
in order to con¢rm the presence of the expressed L-CPT 1. The con-
trol yeast cells used in this study were transformed with the pYeDP1/
8-10 vector alone.
2.2. Yeast culture, isolation of yeast mitochondria and subcellular
fractionation
Yeast strains were cultivated on selective minimal lactate medium
(0.17% yeast nitrogen base without amino acids, 0.5% ammonium
sulfate, 0.1% casamino acids, 2% lactate, 40 mg/ml adenine sulfate,
40 mg/ml L-tryptophan) at 30‡C with shaking. To induce L-CPT 1
expression, 2% galactose was inoculated during the exponential
growth and 10 h later the cells were harvested by centrifugation for
10 min at 3800Ug.
Mitochondria of S. cerevisiae were prepared by di¡erential centri-
fugations. Cells (6^10 g, wet weight) were washed once in 100 ml of
water, resuspended in 50 ml of Tris-SO4 bu¡er (0.1 M Tris-SO4 pH
9.4; 10 mM DTT) and incubated for 10 min at 30‡C with shaking.
After a wash in 50 ml of sorbitol bu¡er (1.2 M sorbitol; 20 mM KPi;
pH 7.4), cells were resuspended in sorbitol bu¡er (6 ml/er g of original
pellet) and converted to spheroplasts by adding 3 mg of Zymolase 20T
per g of cells and the mixture was incubated at 30‡C with shaking for
30^45 min. All subsequent steps were performed at 4‡C. The sphero-
plasts were sedimented by centrifugation at 3800Ug for 10 min,
washed with sorbitol bu¡er and resuspended in 40 ml of SH bu¡er
(0.6 M sorbitol; 20 mM HEPES-KOH; pH 7.4) containing 1 mM
PMSF. After homogenization using 15 strokes of a Dounce homog-
enizer, samples were centrifuged at 2000Ug for 5 min. The super-
natant was decanted and the pellet was similarly rehomogenized
and centrifuged. The supernatants were combined and centrifuged
at 17 000Ug for 12 min. The crude mitochondrial pellet was washed
once and ¢nally resuspended in SH bu¡er. To determine the subcel-
lular localization of the expressed L-CPT 1, the 17 000Ug post-mito-
chondrial supernatant was further centrifuged at 150 000Ug for 1 h at
4‡C. Aliquots of the 150 000Ug pellet and supernatant, and also of
the starting homogenate and mitochondrial fraction, were then ana-
lyzed by SDS-PAGE and immunoblotting.
2.3. Submitochondrial localization of the yeast-expressed L-CPT 1
Hypotonic swelling of mitochondria was performed as previously
described [12] with the following modi¢cations. Mitochondria were
resuspended in the homogenization bu¡er at a concentration of 50
Wg protein/100 Wl and diluted 10-fold in 20 mM HEPES (pH 7.4) in
the absence or presence of 10 or 50 Wg/ml trypsin. Control mitochon-
dria (non-swelling conditions) were diluted to the same extent in SH
bu¡er and also subjected to trypsin treatment, when indicated. Sam-
ples were kept on ice for 30 min and soybean trypsin inhibitor (STI)
was added in a 20-fold excess. Mitoplasts/mitochondria were reiso-
lated and washed once with SH bu¡er containing 1 mM EDTA and
then lysed directly in Laemmli bu¡er. Samples were then analyzed by
SDS-PAGE and immunoblotting.
2.4. Generation of anti-L-CPT 1 antibody
Antibody against amino acids 317^430 of the rat L-CPT 1 was
raised as follows. The BglII-BamHI fragment of L-CPT 1 cDNA
encoding these amino acids was excised from pGEM4-CPT1 plasmid
and subcloned into the pGEX-3X vector (Pharmacia) cut by BamHI.
The resulting plasmid encodes the GST protein fused at its C-terminus
to amino acids 317^430 of L-CPT 1. This plasmid was used to trans-
form the bacterial strain BL21 and the fusion proteins were induced
for 2 h with isopropyl-L-D-thiogalactoside (IPTG; 0.1 mM) and pu-
ri¢ed by a⁄nity chromatography on glutathione Sepharose beads ac-
cording to the manufacturer’s instructions. GST moieties were cleaved
from the puri¢ed fusion proteins by factor Xa cleavage and the L-
CPT 1 peptide was separated by SDS-PAGE electrophoresis and
transferred onto nitrocellulose. The nitrocellulose band containing
the L-CPT 1 peptide was used to immunize New Zealand white rab-
bits following standard procedures.
2.5. Western blot analysis
Aliquots of proteins were subjected to SDS-PAGE [13] in an 8%
gel. The detection of proteins after blotting onto nitrocellulose was
performed as described previously [12] using the ECL detection sys-
tem (Pierce) according to the supplier’s instructions. The antisera used
were against the yeast cytochrome b2 (1/1000), the yeast mitochon-
drial HSP70 (1/5000), the yeast porin (1/1000), the rat L-CPT 1 (1/
3000) and the rat CPT 2 (1/1000).
2.6. Isolation of rat liver mitochondria and digitonin fractionation
Rat liver mitochondria were isolated from Wistar rats (200^300 g)
bred in our laboratory and fed ad libitum on standard laboratory
chow diet (62% carbohydrate, 12% fat and 26% protein in terms of
energy). Mitochondria were isolated and further puri¢ed on self-form-
ing Percoll gradients according to [14]. Puri¢ed mitochondria were
resuspended in the isolation bu¡er (0.3 M sucrose; 5 mM Tris-HCl;
1 mM EGTA; pH 7.4).
Digitonin fractionation was performed as follows: 13 Wl of mito-
chondria (at a concentration of 10 mg protein/ml) was added to 7 Wl
of bu¡er A (250 mM sucrose; 10 mM HEPES; 80 mM KCl; pH 7.6)
containing varying concentrations of digitonin. Samples were incu-
bated for 3 min at 4‡C, diluted with 160 Wl of bu¡er A supplemented
with trypsin (10 Wg/ml ¢nal concentration) and further incubated for
15 min at 30‡C. Protease digestion was stopped with STI (20-fold
excess). After a 10 min incubation at 4‡C, the mitochondria were
recovered by centrifugation, washed once with bu¡er B (250 mM
sucrose; 10 mM HEPES; 1 mM EDTA; pH 7.6) and analyzed by
SDS-PAGE and immunoblotting.
2.7. CPT assay
CPT activity was assayed at 30‡C as palmitoyl-L-[methyl-3H]car-
nitine formed from L-[methyl-3H]carnitine (200 WM; 10 Ci/mol) and
palmitoyl-CoA (80 WM) in the presence of 1% bovine serum albumin
(w/v) as previously described [15]. Malonyl-CoA concentration varied
over 0.01 to 150 WM for estimation of the IC50 value. The apparent
Km for carnitine was measured at 600 WM palmitoyl-CoA with 10^800
WM carnitine. For determination of the Km for palmitoyl-CoA, carni-
tine concentration was 200 WM and palmitoyl-CoA concentration
varied over 20 to 900 WM either in the presence of a ¢xed albumin
amount (1% w/v) or in the presence of a ¢xed molar ratio of palmi-
toyl-CoA/albumin (6.1). When the CPT assay was performed using
detergent-solubilized mitochondria, mitochondria were solubilized by
5% Triton X-100 as described in [8]. The insoluble membrane residue
was sedimented by centrifugation at 16 000Ug for 30 min at 4‡C and
the supernatant was used for the CPT assay. No CPT activity could
be detected in the residual pellet fraction after solubilization.
2.8. Miscellaneous and chemicals
Protein concentration was determined by the Lowry procedure [16].
The ¢delity of the PCR and the quality of DNA subcloning were
con¢rmed by DNA sequence analysis. All restriction enzymes and
T4 DNA ligase were purchased from Gibco (Life Technologies,
France). The PCR reagents and T4 DNA polymerase were from
New England Biolabs. Yeast culture media products were from Difco
and Zymolase 20T from ICN Biomedicals France. L-[methyl-
3H]Carnitine was from Amersham and others chemicals were from
Sigma.
3. Results and discussion
3.1. Rat liver CPT 1 expression in S. cerevisiae and subcellular
localization
In an initial series of experiments, we determined whether
the level of expression of the rat L-CPT 1 in the yeast S.
cerevisiae could be increased by comparison to a previous
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study [7]. We decided to delete the 3P non-coding region
present in the original L-CPT 1 cDNA. Indeed, e⁄cient ex-
pression in yeast requires the deletion of the 5P and 3P non-
coding regions originally present in the heterologous cDNA
before its insertion into a yeast transcription unit [17]. The
pYeDP1/8-10 expression vector was chosen because of its pre-
viously reported ability to express another mammalian OMM
protein in S. cerevisiae [18]. In yeast cells grown in the pres-
ence of glucose, a large number of genes including several
encoding mitochondrial respiratory enzymes are repressed
[19,20], thus a¡ecting mitochondrial biogenesis [21,22]. There-
fore, yeast cells were grown on lactate as a non-fermentable
carbon source before galactose induction of L-CPT 1.
Fig. 1A shows that our antibody raised against the rat L-
CPT 1 strongly recognized the 88 kDa L-CPT 1 protein on
Western blots of puri¢ed rat liver mitochondria and failed to
detect any protein in the region of 68 kDa which is the size of
the rat CPT 2 protein [23] (lane 3). This illustrates that the
anti-L-CPT 1 antibody is speci¢c and does not cross-react
with the rat CPT 2 protein. This speci¢c L-CPT 1 antibody
could readily detect a 88 kDa protein in the homogenate of
yeast cells transformed with pYeCPT1 and no speci¢c signal
was detected in the region of 88 kDa in control yeast cells
transformed with the empty vector (Fig. 1A, compare lanes 1
and 2). Moreover, the immunoreactive protein expressed in
yeast co-migrated with the native rat L-CPT 1 (Fig. 1A, com-
pare lanes 2 and 3) suggesting that L-CPT 1 was indeed ex-
pressed in yeast. In support of this, antibody raised against
the rat CPT 2 recognized the CPT 2 protein in puri¢ed rat
liver mitochondria (Fig. 1A, lane 6) but failed to recognize the
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Fig. 1. Heterologous expression of the rat L-CPT 1 in S. cerevisiae.
A: Immunodetection of the rat L-CPT 1 expressed in S. cerevisiae
using an anti-L-CPT 1 antibody. A SDS-PAGE gel was run using
paired amounts of protein from either homogenate of yeast cells (40
Wg of protein) or isolated mitochondria from adult fed rat (80 Wg of
protein). Proteins were transferred onto nitrocellulose and one half
of the blot was probed with an antibody against the rat L-CPT 1
(lanes 1^3) whereas the other half was probed with an antibody
against the rat CPT 2 (lanes 4^6). Lanes 1 and 4: homogenate from
control yeast cells; lanes 2 and 5: homogenate from yeast express-
ing the rat L-CPT 1; lanes 3 and 6: puri¢ed rat liver mitochondria.
B: Subcellular localization of L-CPT 1 expressed in S. cerevisiae.
Subcellular fractions were prepared from control yeast cells
(W303pYe) and cells transformed with pYeCPT1 (W303pYeCPT1)
as described in Section 2. 50 Wg of protein from each subcellular
fraction was analyzed by SDS-PAGE followed by immunoblotting
with anti-L-CPT1 antibody. The quality of the subfractionation was
assessed by immunoblotting with an anti-yeast porin antibody.
Fig. 2. Native and S. cerevisiae-expressed L-CPT 1 shared the same
folded conformation. A: Trypsin proteolysis of intact or digitonin-
treated rat liver mitochondria. Intact rat liver mitochondria were in-
cubated for 3 min at 4‡C in the presence of an increasing digitonin
concentration (see Section 2). After dilution, samples were further
incubated either in the absence or in the presence of trypsin (10 Wg/
ml) for 15 min at 30‡C. Then soybean trypsin inhibitor was added
and the samples were sedimented, washed and electrophoresed on
SDS-PAGE. Western blot analysis was performed using anti-L-CPT
1 and anti-CPT 2 antibodies. Results are representative of three ex-
periments. The arrow indicates a 83 kDa L-CPT 1 fragment gener-
ated by trypsin proteolysis in digitonin-treated mitochondria. B:
Submitochondrial localization and topology of the L-CPT 1 ex-
pressed in S. cerevisiae. Mitochondria isolated from yeast expressing
L-CPT 1 were incubated for 30 min at 4‡C under either iso-
(3swelling) or hypoosmotic (+swelling) conditions in the absence or
in the presence of trypsin (10 or 50 Wg/ml). After addition of soy-
bean trypsin inhibitor, samples were sedimented, washed, electro-
phoresed on SDS-PAGE and analyzed by Western blot. Marker
proteins for the di¡erent yeast mitochondrial subcompartments were
cytochrome b2 for the intermembrane space and mitochondrial
HSP70 for the soluble matrix proteins. Results are representative of
four di¡erent experiments. The arrow indicates a 83 kDa L-CPT 1
fragment generated by trypsin proteolysis in swollen yeast mitochon-
dria.
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yeast-expressed L-CPT 1 (Fig. 1A, lane 5). Subcellular frac-
tionation showed that L-CPT 1 expressed in yeast was local-
ized exclusively to the mitochondrial pellet fraction, as was
true for another OMM protein, the yeast porin (Fig. 1B).
Thus, the present study clearly shows that S. cerevisiae can
be used to obtain a signi¢cant level of L-CPT 1 protein that is
correctly targeted to yeast mitochondria. The very low level of
expression of L-CPT 1 in S. cerevisiae reported earlier [7] was
likely due to di¡erent experimental procedures for yeast ex-
pression and/or to the presence of the 3P non-coding region in
the L-CPT 1 cDNA used in these studies.
3.2. Submitochondrial localization of the yeast-expressed
L-CPT 1
A recent topological analysis indicated that rat L-CPT 1 is
an integral OMM protein with two transmembrane domains,
both the N- and C-termini being exposed on the cytosolic side
of the OMM [24]. The second aim of the present study was to
determine if L-CPT 1 expressed in S. cerevisiae was inserted
into the OMM in a conformation similar to that of the native
enzyme despite possible changes in the phospholipid compo-
sition and/or £uidity of the OMM between these two species.
Experimental conditions were ¢rst designed to verify
whether endogenous rat L-CPT 1 was resistant to a low tryp-
sin concentration in intact mitochondria but not in digitonin-
treated mitochondria. When intact rat liver mitochondria
were incubated at 30‡C for 15 min, L-CPT 1 was resistant
to 10 Wg/ml of trypsin (Fig. 2A) but was digested by higher
trypsin concentrations (data not shown). Treatment of these
mitochondria with 0.25 mg of digitonin/mg of protein resulted
in solubilization of the OMM, as shown by the disappearance
of L-CPT 1 protein (Fig. 2A). The IMM remained intact in
the presence of 0.25^1.0 mg of digitonin/mg of protein since
rat liver CPT 2 sedimented with the digitonin-permeabilized
mitochondria (Fig. 2A). Rat liver CPT 2 was solubilized only
at higher digitonin concentrations (above 2 mg of digitonin/
mg of protein; data not shown). When the fractionation was
performed in the presence of trypsin (10 Wg/ml), L-CPT 1 was
partially degraded into a 83 kDa fragment, but only when the
OMM was disrupted (Fig. 2A). These results support a pre-
vious study [24] indicating that native L-CPT 1 adopts a
highly folded state when anchored in the OMM and that sites
sensitive to low concentrations of trypsin become accessible
only when the OMM is disrupted.
To examine the submitochondrial localization of the L-CPT
1 expressed in yeast, intact mitochondria or hypotonic swollen
mitochondria (mitoplasts) were subjected to trypsin treatment.
Swelling experiments were performed rather than digitonin
fractionation because experimental procedures for yeast mito-
chondria swelling were already established [12]. L-CPT 1 ex-
pressed in intact yeast mitochondria was resistant to a low
trypsin concentration (10 Wg/ml) but was nearly completely
degraded by 50 Wg/ml of trypsin without generation of any
detectable proteolytic fragments (Fig. 2B). The yeast OMM
was intact since endogenous cytochrome b2, a soluble inter-
membrane space protein, was not degraded in the presence of
trypsin (Fig. 2B). Hypotonic swelling of mitochondria was
e⁄cient since at least 90% of the cytochrome b2 protein was
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Fig. 3. Carnitine and palmitoyl-CoA saturation curves for the native and S. cerevisiae-expressed L-CPT 1. Intact mitochondria (50 Wg) isolated
from yeast expressing L-CPT 1 (a, b) or from adult fed rat liver (E, F) were assayed for CPT activity either at 600 WM palmitoyl-CoA with
increasing concentrations of carnitine (A and B) or at 200 WM carnitine with increasing concentrations of palmitoyl-CoA (C and D). CPT assay
was performed either in the presence of a ¢xed albumin concentration (1% w/v; a, E) or a ¢xed molar ratio of palmitoyl-CoA/albumin (6.1:1;
b, F). Results are means þ S.E.M. of four separate experiments.
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released and the remainder was digested by trypsin. By con-
trast, a mitochondrial matrix protein, HSP70, was still present
in the mitoplasts and was not digested by trypsin (Fig. 2B).
Under swelling conditions, and in the presence of 10 Wg/ml of
trypsin, L-CPT 1 expressed in yeast was cleaved to a 83 kDa
fragment that was similar in size to that observed in the rat
liver digitonin-disrupted mitochondria (Fig. 2A). These results
indicate that L-CPT 1 expressed in yeast was correctly tar-
geted and inserted into in the OMM, and adopted the same
folded conformation as the native rat L-CPT 1, at least in
terms of behavior towards trypsin treatment.
3.3. Functional analysis of the yeast-expressed L-CPT 1
The next step was to compare the biochemical properties of
L-CPT1 expressed in S. cerevisiae with those of the native
enzyme. Malonyl-CoA-sensitive CPT activity was observed
only in mitochondria isolated from cells transformed with
pYeCPT 1 (Table 1), con¢rming that S. cerevisiae mitochon-
dria were devoid of endogenous CPT activity [7]. CPT activity
in mitochondria from the transformed cells was 240% higher
than in those isolated from the liver of fed rats (Table 1).
Moreover, 93% of the CPT activity present in yeast mitochon-
dria was inhibited by 150 WM malonyl-CoA (Table 1). As
expected [7,8], detergent solubilization completely abolished
the malonyl-CoA-sensitive enzyme expressed in yeast mito-
chondria and left essentially no residual CPT activity (Table
1). These observations clearly showed that the protein ex-
pressed in S. cerevisiae was indeed L-CPT 1. By contrast,
CPT activity measured in detergent-solubilized rat liver mito-
chondria was increased in comparison to that monitored in
intact organelles (Table 1). This results from the fact that,
despite inactivation of L-CPT 1 by detergents, active soluble
CPT 2 is released from detergent-solubilized rat liver mito-
chondria [23]. However, in this case a small residual sensitivity
to malonyl-CoA was observed (Table 1), as reported previ-
ously in studies with rat liver mitochondria [25] and yeast cells
expressing CPT 2 [8]. Its signi¢cance is still unclear. Impor-
tantly, in the present study, the IC50 value for malonyl-CoA
of L-CPT 1 expressed in yeast was similar to the one found
for the native enzyme (0.67 þ 0.13 WM for yeast versus
1.05 þ 0.23 WM for rat liver). This is the ¢rst study that reports
clearly similar sensitivity to malonyl-CoA inhibition for both
the yeast-expressed and native rat L-CPT 1 despite possible
changes in the phospholipid composition and/or £uidity of the
OMM between these two species. It has been proposed that
variations in the sensitivity of L-CPT 1 to malonyl-CoA in-
hibition that occur in vivo may result from changes in con-
formation of the enzyme (reviewed in [1]). Thus, the observed
similarity in the IC50 value of the native and yeast-expressed
proteins strengthens the view that both products adopt a sim-
ilar conformation.
3.4. Substrate saturation curves for the yeast-expressed
L-CPT 1
Both yeast-expressed (Fig. 3A) and native (Fig. 3B) L-CPT
1 exhibited normal saturation kinetics with respect to carni-
tine. In yeast mitochondria expressing L-CPT 1, the calculated
Vmax and the apparent Km for carnitine were respectively
26.4 þ 0.5 nmol/min/mg of protein and 87 þ 3 WM, whereas,
when measured in rat liver mitochondria, the values were
respectively 4.7 þ 0.5 nmol/min/mg of protein and 95 þ 2
WM. Thus, similar a⁄nities for carnitine were observed for
both native and yeast-expressed L-CPT 1 and the ¢ve-fold
increase in the Vmax for carnitine of the yeast-expressed L-
CPT 1 illustrates the e⁄ciency of the expression in yeast. It
was reported recently that both rat liver CPT 1 and CPT 2
expressed in the yeast P. pastoris exhibited non-Michaelis-
Menten saturation kinetics in response to an increasing pal-
mitoyl-CoA concentration (20^300 WM) [8]. As seen from Fig.
3C, over a larger range of palmitoyl-CoA concentrations in
the presence of 1% albumin, the kinetic curve was in fact
sigmoidal, in keeping with previous observations [26^28].
Under these conditions, it is not possible to determine the
Km or Vmax for palmitoyl-CoA. Although the allosteric behav-
ior of L-CPT 1 towards its substrates and its inhibitor is still a
subject of controversy, artefactual sigmoidicity has been at-
tributed to substrate binding to albumin [28,29]. At low pal-
mitoyl-CoA concentrations, binding sites on albumin may
compete very e¡ectively for palmitoyl-CoA, resulting in an
underestimation of the actual CPT 1 activity for the total
concentration of palmitoyl-CoA in the assay medium. The
problem could be solved by using a 6.1:1 molar ratio of pal-
mitoyl-CoA/albumin [28]. When we perform the CPT assay
under these conditions, L-CPT 1 expressed in yeast exhibited
a normal hyperbolic saturation kinetic curve for palmitoyl-
CoA (Fig. 3C). From the Lineweaver-Burk plot, which was
now linear, an apparent Km (45 þ 7 WM) and Vmax (25.7 þ 2.2
nmol/min/mg of protein) for palmitoyl-CoA could be deter-
mined. When the CPT assay was performed with rat liver
mitochondria by using this 6.1:1 molar ratio of palmitoyl-
CoA/albumin, the apparent Km value for palmitoyl-CoA
(16 þ 2 WM) and the Vmax (5.2 þ 0.8 nmol/min/mg of protein)
were very similar to those reported previously for the rat liver
enzyme [30], but di¡erent from those obtained in yeast. Be-
cause the increased Vmax of the L-CPT 1 expressed in yeast
was accompanied by an increase in the apparent Km for pal-
mitoyl-CoA, mechanisms other than the presence of an in-
creased amount of protein in yeast mitochondria have to be
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Table 1
Characteristics of the L-CPT 1 activity expressed in yeast mitochondria
Stem Intact mitochondria Detergent-solubilized mitochondria
Malonyl-CoA % inhibition Malonyl-CoA % inhibition
3 + 3 +
W303pYe undetectable undetectable ^ ^ ^ ^
W303pYeCPT1 3.20 þ 0.20 0.20 þ 0.03 93.7 þ 0.8 0.023 þ 0.008 0.026 þ 0.004 0
Rat liver 1.31 þ 0.19 0.15 þ 0.02 88.6 þ 4.4 2.30 þ 0.20 1.68 þ 0.18 26.9 þ 6.2
Mitochondria were isolated from control yeast cells (W303pYe), yeast cells expressing L-CPT 1 (W303pYeCPT 1) and from fed rat liver. CPT
activity was assayed with 80 WM palmitoyl-CoA and 200 WM carnitine in the absence or in the presence of 150 WM malonyl-CoA, using either intact
mitochondria or mitochondria solubilized in 5% Triton X-100, as described in Section 2. The % inhibition of CPT activity by 150 WM malonyl-CoA
is indicated. CPT activity is expressed in nmol/min/mg protein. Results are means þ S.E.M. of three to seven separate experiments.
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considered. Since alterations in protein conformation seem
unlikely (see above), a possible explanation could be the ab-
sence in yeast cells of a liver-speci¢c modi¢cation involving
membrane lipid environment and/or protein/protein interac-
tion. It should also point out that when the CPT assay was
performed with rat liver mitochondria by using 1% albumin
and varied palmitoyl-CoA concentrations, the kinetic curve
was not sigmoidal (Fig. 3D) by contrast to what observed
for the L-CPT 1 expressed in yeast (Fig. 3C). This discrepancy
between yeast-expressed and native L-CPT 1 may result from
the decreased a⁄nity for palmitoyl-CoA observed for the
yeast-expressed L-CPT 1.
In summary, we demonstrate here that: (1) a high level of
expression of an active rat L-CPT 1 can be obtained in S.
cerevisiae, (2) the expressed protein is correctly targeted to the
OMM and exhibits the same sensitivity to malonyl-CoA and
membrane topology as the native enzyme and (3) kinetic pa-
rameters (Km, Vmax) of the yeast-expressed L-CPT 1 can be
measured for both carnitine and palmitoyl-CoA with careful
attention to the experimental conditions of the CPT assay,
allowing further site-directed mutagenesis analysis of the ami-
no acid residues involved in the interaction between L-CPT 1
and palmitoyl-CoA or carnitine. Thus, S. cerevisiae represents
a valid model for the study of the structure-function relation-
ships of L-CPT 1.
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